ZyCoV-D%2C%20the%20vaccine%20manufactured%20by%20Gujarat%20based%20Cadila%20healthcare%2C%20is%20currently%20in%20its%20phase%203%20trials%2C%20involving%2028%2C000%20participants.%20Reportedly%2C%20the%20vaccine%20uses%20plasmid%20DNA%2C%20which%2C%20when%20introduced%20to%20host%20cells%2C%20kills%20the%20COVID-19%20infection.
A%20plasmid%20cell%20is%20a%20double%20stranded%20DNA%20molecule%20which%20is%20distinct%20from%20a%20cell%u2019s%20chromosomal%20DNA%2C%20and%20are%20naturally%20found%20in%20bacteria%20cells.
%3Cstrong%3EAlso%20read%3A%20%3C/strong%3E%3Ca%20target%3D%22_blank%22%20rel%3D%22noopener%20noreferrer%22%20href%3D%22https%3A//opoyi.com/india-records-346786-covid-19-cases-2624-deaths-in-last-24-hours%22%3E%3Cstrong%3EIndia%20records%20346%2C786%20COVID-19%20cases%2C%202%2C624%20deaths%20in%20highest%20single%20day%20spike%3C/strong%3E%3C/a%3E
The%20company%2C%20which%20started%20working%20on%20the%20vaccine%20in%20February%202020%2C%20expects%20its%20phase%203%20trial%20results%20to%20be%20out%20in%20May%2C%20and%20as%20per%20reports%20referring%20to%20company%20officials%2C%20the%20vaccine%20can%20possibly%20come%20out%20in%20late%20in%20May%20or%20early%20June.
The%20price%20of%20ZyCoV-D%20will%20be%20around%20the%20price%20range%20of%20other%20vaccines%20available%20in%20India%20at%20the%20moment.%20The%20manufacturer%20is%20also%20looking%20to%20increase%20its%20production%20capacity%20post-launch.%20Reportedly%2C%20the%20current%20capacity%20of%20120-150%20million%20doses%20a%20year.
While%20the%20expected%20dosage%20is%20a%20three-dose%20regimen%2C%20a%20two-dose%20one%2C%20too%2C%20is%20currently%20being%20tested%20out.%26nbsp%3B
In%20case%20of%20ZyCov-D%20being%20approved%2C%20it%20would%20be%20the%20second%20indigenously%20developed%20vaccine%20gaining%20regulatory%20approval%20in%20India.
%3Cstrong%3EAlso%20read%3A%20%3C/strong%3E%3Ca%20target%3D%22_blank%22%20rel%3D%22noopener%20noreferrer%22%20href%3D%22https%3A//opoyi.com/biden-administration-under-pressure-to-dispatch-astrazeneca-vaccines-to-india%22%3E%3Cstrong%3EBiden%20administration%20under%20pressure%20to%20dispatch%20AstraZeneca%20vaccines%20to%20India%3C/strong%3E%3C/a%3E
Currently%20in%20India%2C%20only%20two%20vaccines%20are%20being%20used%20for%20the%20inoculation%20process%3A%20Covishield%2C%20manufactured%20by%20Pune-based%20Serum%20Institute%20of%20India%20and%20Covaxin%2C%20produced%20by%20Hyderabad-based%20Bharat%20Biotech.
%3Ca%20class%3D%22mention%22%20data-mention%3D%22%23covid19%22%20data-user-id%3D%22S9X5iTjQfBZD%22%20href%3D%22/topic/covid19%22%3E%23covid19%3C/a%3E%20%3Ca%20class%3D%22mention%22%20data-mention%3D%22%23Vaccine%22%20data-user-id%3D%22zyoa0s9Rqx9V%22%20href%3D%22/topic/vaccine%22%3E%23Vaccine%3C/a%3E%20%3Ca%20class%3D%22mention%22%20data-mention%3D%22%23Health%22%20data-user-id%3D%222pSwu97y4loa%22%20href%3D%22/topic/health%22%3E%23Health%3C/a%3E%26nbsp%3B
